Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis (Pso23)

NCT05111210 RECRUITING

This is a research study involving humans, of the interventional type with minimal risks and constraints (RIPH2). It is a monocentric, non randomized prospective study aiming to better understand the mechanisms of the response to anti-IL-23 biologics in psoriasis patients attending the dermatology department of hospital Cochin (APHP).

Details

Lead sponsor	Institut Pasteur
Status	RECRUITING
Enrolment	90
Start date	Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Psoriasis

Interventions

• Blood sample
• Data collection
• skin biopsies

Countries

France